Kylonova (Xiamen) Biopharma co., LTD.
Kylonova (Xiamen) Biopharma co., LTD.
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a) | Lipoprotein Disorder | Recruiting | Phase 2 | 2026-06-25 | NCT07327840 | |
| Single-ascending Dose Study of Kylo-12 in Healthy Subjects | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, hyperlipidemia, hypertriglyceridemia, metabolic disease | Active, not recruiting | Phase 1 | 2026-03-16 | NCT06783881 |